Literature DB >> 23700286

Recruitment and phenotypic characteristics of interleukin 9-producing CD4+ T cells in malignant pleural effusion.

Xiao-Ning Bu1, Qiong Zhou, Jian-Chu Zhang, Zhi-Jian Ye, Zhao-Hui Tong, Huan-Zhong Shi.   

Abstract

BACKGROUND: Our previous data have demonstrated that the number of IL-9-producing CD4(+) T cells (Th9 cells) in malignant pleural effusion (MPE) was significantly increased when compared with that in blood. The aim of the present study was to investigate the mechanism by which Th9 cells were recruited into MPE and the phenotypic characteristics of pleural Th9 cells.
METHODS: The expression patterns of chemokine receptors (CCRs) on Th9 cells and the chemoattractant activity of chemokine CCL20 for Th9 cells in vitro were observed. The phenotypic features of Th9 cells in MPE were determined by flow cytometry.
RESULTS: We found that Th9 cells in both MPE and blood expressed a high level of CCR6 on their surface. An in vitro migration assay confirmed that both MPE and supernatants of cultured pleural mesothelial cells could induce the migration of Th9 cells, and anti-CCL20 mAb significantly inhibited the ability of MPE or supernatants to stimulate Th9 cell chemotaxis. We also noted that pleural Th9 cells expressed high levels of CD45RO and very low levels of CD45RA and CD62L, displaying the phenotype of effector memory cells.
CONCLUSIONS: Our data revealed that recruitment of Th9 cells into MPE could be induced by pleural CCL20 and that the majority of Th9 cells in MPE displayed the phenotype of effector memory cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23700286     DOI: 10.1007/s00408-013-9474-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  15 in total

1.  Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.

Authors:  Mark E Roberts; Edmund Neville; Richard G Berrisford; George Antunes; Nabeel J Ali
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

2.  Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy.

Authors:  Zhi-Jian Ye; Qiong Zhou; Ming-Li Yuan; Rong-Hui Du; Wei-Bing Yang; Xian-Zhi Xiong; Bo Huang; Huan-Zhong Shi
Journal:  Am J Respir Crit Care Med       Date:  2011-12-28       Impact factor: 21.405

Review 3.  From interleukin-9 to T helper 9 cells.

Authors:  Michael Stassen; Edgar Schmitt; Tobias Bopp
Journal:  Ann N Y Acad Sci       Date:  2012-01-11       Impact factor: 5.691

Review 4.  Malignant pleural effusion: tumor-host interactions unleashed.

Authors:  Georgios T Stathopoulos; Ioannis Kalomenidis
Journal:  Am J Respir Crit Care Med       Date:  2012-05-31       Impact factor: 21.405

5.  Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.

Authors:  Nick A Maskell; Y C Gary Lee; Fergus V Gleeson; Emma L Hedley; Gerry Pengelly; Robert J O Davies
Journal:  Am J Respir Crit Care Med       Date:  2004-05-13       Impact factor: 21.405

6.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

9.  Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection.

Authors:  Zhi-Jian Ye; Ming-Li Yuan; Qiong Zhou; Rong-Hui Du; Wei-Bing Yang; Xian-Zhi Xiong; Jian-Chu Zhang; Cong Wu; Shou-Ming Qin; Huan-Zhong Shi
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  10 in total

1.  Recruitment and significance of Th22 cells and Th17 cells in malignant ascites.

Authors:  Xian-Wen Yang; Hai-Xing Jiang; Ronge Lei; Wei-Shun Lu; Shi-Hui Tan; Shan-Yu Qin
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

Review 2.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

3.  Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy.

Authors:  Xinyue Hu; Juntao Feng; Shuanglinzi Deng; Jiale Tang; Zhonghua Liao; Lisha Luo; Liying Luo; Ting Meng; Guanghui Gong; Xiaozhao Li
Journal:  J Nephrol       Date:  2020-02-08       Impact factor: 3.902

Review 4.  Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?

Authors:  Nicola Principe; Joel Kidman; Richard A Lake; Willem Joost Lesterhuis; Anna K Nowak; Alison M McDonnell; Jonathan Chee
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 5.  TH9 cells in anti-tumor immunity.

Authors:  Thaiz Rivera Vargas; Etienne Humblin; Frédérique Végran; François Ghiringhelli; Lionel Apetoh
Journal:  Semin Immunopathol       Date:  2016-11-10       Impact factor: 9.623

6.  Human umbilical cord mesenchymal stem cells increase interleukin-9 production of CD4+ T cells.

Authors:  Zhou Xin Yang; Ying Chi; Yue Ru Ji; You Wei Wang; Jing Zhang; Wei Feng Luo; Li Na Li; Cai Dong Hu; Guang Sheng Zhuo; Li Fang Wang; Zhi-Bo Han; Zhong Chao Han
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

7.  IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.

Authors:  Jon N Buzzelli; Heather V Chalinor; Daniel I Pavlic; Philip Sutton; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01-03

Review 8.  NSFC spurs significant basic research progress of respiratory medicine in China.

Authors:  Ruijuan Sun; Feng Xu; Chen Wang; Erdan Dong
Journal:  Clin Respir J       Date:  2015-08-12       Impact factor: 2.570

9.  Expression and clinical significance of interleukin-9 in renal tumors.

Authors:  Zhiyu Zhang; Qi Zhou; Jun Ouyang; Jinxian Pu; Jianquan Hou; Jianglei Zhang
Journal:  Transl Androl Urol       Date:  2020-12

10.  The Role of IL-9 Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma.

Authors:  Agne Pasvenskaite; Rasa Liutkeviciene; Greta Gedvilaite; Alvita Vilkeviciute; Vykintas Liutkevicius; Virgilijus Uloza
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.